Home Blog Vertical AI and Industry Sol AI for remote patient monitoring: wearables and IoT
πŸ₯ Vertical AI and Industry Sol June 16, 2026 12 min read

AI for remote patient monitoring: wearables and IoT

Vertical AI and Industry Sol Enterprise Guide 2026 SCALE D2C Vertical AI and Industry Sol Enterprise Guide 2026

AI-powered remote patient monitoring (RPM) β€” combining continuous wearable sensor data with machine learning to identify deteriorating patients before clinical crisis β€” is reducing hospital readmissions by 20–30% and enabling earlier intervention for chronic disease patients who previously had no real-time clinical oversight. FDA-cleared RPM AI systems are now deployed at scale in cardiovascular, diabetes, COPD, and post-surgical monitoring programmes. This guide covers the technology architecture, FDA regulatory pathway, and enterprise deployment approach for health system technology leaders.

RPM Technology Stack

LayerComponentsEnterprise Examples
Wearable sensorsContinuous ECG, SpO2, heart rate, activity, blood pressure, CGMApple Watch, AliveCor KardiaMobile, Dexcom G7, Withings ScanWatch
IoT connectivityCellular (LTE-M), Bluetooth β†’ phone β†’ cloudVerizon ThingSpace, AWS IoT Core, Azure IoT Hub
AI/ML layerAnomaly detection, deterioration prediction, alert prioritisationCurrent Health AI, Biofourmis, Cardiogram, custom ML
Clinical workflowEscalation to nursing team, EHR integration, care plan adjustmentEpic MyChart, Salesforce Health Cloud, custom portals
Patient engagementPatient app, symptom questionnaires, medication remindersTwilio messaging, custom PWA, Dario Health platform
25%
Reduction in 30-day hospital readmissions for heart failure patients enrolled in AI-powered RPM programmes vs standard discharge β€” the primary ROI driver for payers and risk-bearing providers
48h
Median advance warning time before clinical deterioration identified by current RPM AI systems β€” early enough for outpatient intervention in most cases, preventing emergency admission
CPT 99453
US RPM reimbursement code β€” CMS reimburses RPM programme setup ($19) and monthly monitoring ($57/month) for qualifying chronic disease patients, creating the reimbursement model that makes RPM financially sustainable
❀️
Cardiac RPM
Continuous ECG patches (Zio XT, BioTelemetry) for post-discharge arrhythmia monitoring; wearable blood pressure (Withings, Omron) for hypertension management; AI analysis detects AFib, hypertensive crisis, and heart failure decompensation. Current Health's AI platform integrates multi-sensor cardiac RPM with Epic EHR for seamless clinical workflow. FDA-cleared for cardiac monitoring indications. The highest-volume RPM use case in US health systems.
🩺
Diabetes Management
Continuous glucose monitors (Dexcom G7, Libre 3) provide real-time glucose data to AI that predicts hypoglycaemic episodes 30 minutes before they occur β€” alerting both the patient and the care team. Integrated with insulin pump data for closed-loop management. Dario Health and Omada's enterprise diabetes programmes combine CGM, AI coaching, and RPM for employer-sponsored chronic disease management with measured HbA1c reduction outcomes.
🫁
COPD and Respiratory Monitoring
SpO2 + respiratory rate + activity monitoring for COPD and post-COVID patients at risk of exacerbation. AI detects the 3–5 day physiological signal that precedes COPD exacerbations β€” enabling outpatient antibiotic/steroid intervention before hospitalisation. Biofourmis and VitalConnect provide FDA-cleared patch sensors with AI analysis for respiratory RPM. COPD readmission reduction is one of the highest-ROI RPM use cases for hospitals under value-based care arrangements.
πŸƒ
Post-Surgical Recovery
Activity, vital sign, and wound sensor monitoring for total joint replacement, bariatric, and cardiac surgery patients in the 30–90 days post-discharge. AI identifies deviations from expected recovery trajectories β€” reduced activity, abnormal temperature, irregular vitals β€” and escalates to the surgical team for intervention. Reduces post-surgical complication-related readmissions by 30–40% in pilot deployments. Integrates with Epic Care Everywhere for surgical team review without leaving their existing workflow.
⚠ FDA, HIPAA, and Clinical Governance Requirements

AI-powered RPM systems that influence clinical decision-making require FDA clearance (Class II, 510(k) pathway for most RPM AI functions). All PHI transmitted from wearables through the RPM platform requires HIPAA-compliant infrastructure with BAA. Clinical governance: every RPM alert must have a defined clinical escalation pathway β€” who receives the alert, what are they expected to do, and what is the response time expectation. Without clear escalation protocols, RPM alert fatigue creates liability rather than value.

RPM Programme Implementation

Our healthcare app development, IoT solutions, and ML development teams design and deploy HIPAA-compliant AI-powered RPM programmes for health systems and payers. Book a free advisory session.

Frequently Asked Questions

End-to-end Vertical AI and Industry Sol strategy, implementation, and optimisation. Contact us for a free consultation.

Strategy: 4–8 weeks. Full implementation: 3–12 months.

Yes β€” D2C brands to enterprise. View our pricing.

VERTICAL AI

Ready to Implement Vertical AI and Industry Sol?

Our specialist team delivers measurable ROI for enterprise and D2C brands.

Free Audit